Academic Journal
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
العنوان: | Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial |
---|---|
المؤلفون: | Braithwaite, Irene E., Cai, Fang, Tom, Jennifer A., Galanter, Joshua M., Owen, Ryan P., Zhu, Rui, Williams, Mathew, McGregor, Anna G., Eliahu, Avi, Durk, Matthew R., Dengler, Hart S., Zak, Mark, Kenny, Jane R., Wilson, Maria E., Beasley, Richard, Chen, Hubert |
المساهمون: | Genentech Inc |
المصدر: | Journal of Allergy and Clinical Immunology ; volume 148, issue 3, page 783-789 ; ISSN 0091-6749 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.jaci.2021.02.042 |
الاتاحة: | http://dx.doi.org/10.1016/j.jaci.2021.02.042 https://api.elsevier.com/content/article/PII:S009167492100422X?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S009167492100422X?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
رقم الانضمام: | edsbas.A7DDE442 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.jaci.2021.02.042 |
---|